9JSE

Crystal Structure of PenI beta-Lactamase from Burkholderia pseudomallei Complex with Taniborbactam

Summary for 9JSE

• Entry DOI: 10.2210/pdb9jse/pdb
• Related: 3W4O 3W4P
• Descriptor: Beta-lactamase, (3~{R})-3-[2-[4-(2-azanylethylamino)cyclohexyl]ethanoylamino]-2-oxidanyl-3,4-dihydro-1,2-benzoxaborinine-8-carboxylic acid, GLYCEROL, ... (4 entities in total)
• Functional Keywords: beta-lactamase, hydrolase
• Biological source: Burkholderia pseudomallei K96243
• Total number of polymer chains: 1
• Total formula weight: 28604.14

Authors

Nukaga, M.,Hoshino, T.,Mojica, M.F.,Papp-Wallace, K.M. (deposition date: 2024-09-30, release date: 2025-08-13, Last modification date: 2025-10-15)

Primary citation

Mojica, M.F.,Becka, S.A.,Edwards, M.,Myers, C.,Uehara, K.,Uehara, T.,Hoshino, T.,Zeiser, E.T.,Chatwin, C.L.,Six, D.A.,Bonomo, R.A.,Papp-Wallace, K.M.,Nukaga, M.
Burkholderia pseudomallei PenI beta-lactamase and variants are potently inhibited by taniborbactam.
Antimicrob.Agents Chemother., 69:e0078725-e0078725, 2025

PubMed Abstract: is a Gram-negative pathogen that causes melioidosis, a severe and often fatal disease. Due to its recognized potential as a bioterrorism agent, it is critical that appropriate antimicrobial agents are available for post-exposure prophylaxis and treatment of melioidosis. Cefepime-taniborbactam is a novel β-lactam-β-lactamase inhibitor combination in clinical development, with promising activity against Gram-negative bacteria producing class A, B, C, and/or D β-lactamases. Herein, we demonstrate the inhibitory activity of taniborbactam against PenI, the class A β-lactamase produced by . Isogenic strains producing PenI and its ceftazidime-resistance-conferring variants (C69Y and P167S) showed ceftazidime minimum inhibitory concentration (MIC) of 64 mg/L for the strain producing PenI and 1,024 mg/L for the strains producing the variants, whereas cefepime MIC was 128-256 mg/L for these three strains. While the addition of avibactam decreased ceftazidime MIC to 1 mg/L for PenI and 8-16 mg/L for the variants, the addition of taniborbactam decreased cefepime MIC to ≤0.5 mg/L for PenI and the variants. Similarly, an 8-fold reduction of the cefepime MIC upon addition of taniborbactam was observed in an avirulent strain. Furthermore, taniborbactam inhibited PenI and its C69Y variant with an apparent of 0.11 and 3.1 µM, respectively. Lastly, co-crystallography and molecular dynamics simulations showed that taniborbactam induced the formation of a disulfide bond between Cys77 and Cys123, which destabilizes the deacylation water and strengthens the taniborbactam-PenI complex. These results support the development of cefepime-taniborbactam as a promising agent for the treatment of infections by .

PubMed: 40938351
DOI: 10.1128/aac.00787-25

Experimental method

X-RAY DIFFRACTION (1.25 Å)